Skip to main content
Fig. 1 | BMC Complementary Medicine and Therapies

Fig. 1

From: Shikonin reactivates TSGs GADD45B and PPP3CC to block NSCLC cell proliferation and migration through JNK/P38/MAPK signaling pathways

Fig. 1

Shikonin inhibits the cell viability of A549 and H1299 cells in dose-dependent manner. A. The chemical structure of shikonin. B-C. The cell viability of A549 and H1299 cells was determined by CCK8 assays. D. The respective IC50 in A549 and H1299 cells was calculated. E. The cell viability of HCoEpi cells was determined by a CCK8 assay. F-G. Shikonin was able to inhibit the cell growth of A549 and H1299 cells in a dose-dependent manner. **** represents p < 0.0001, *** represents p < 0.001

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us